An FDA Import Alert is an official FDA directive identifying products or manufacturers that appear to violate FDA regulations. Once listed, shipments are automatically detained without physical examination at every U.S. port of entry. FDA Registration Assistance can help you understand your alert status and begin the removal process immediately.

DWPE means your shipments are detained automatically at the port of entry based on a prior violation record — without the FDA needing to physically inspect the goods. This applies to every shipment until the Import Alert is removed. FDA Registration Assistance works to resolve your DWPE status as efficiently as possible.

FDA Import Alerts are publicly searchable on the FDA website. Importers should verify Import Alert status before shipping any product to the U.S. FDA Registration Assistance can conduct a full Import Alert status review on your behalf and advise on next steps.

Removal typically requires demonstrating five consecutive compliant shipments, preparing corrective action documentation, and submitting a formal petition to the FDA. FDA Registration Assistance manages the entire process from compliance preparation through petition submission and ongoing FDA communication.

Timelines vary depending on the type of violation, product category, and quality of documentation submitted. Professional assistance can significantly improve efficiency and reduce delays. FDA Registration Assistance works to move your case forward as efficiently as possible.

Yes. FDA Registration Assistance provides complete end-to-end support — from initial case assessment and compliance strategy through documentation preparation, petition filing, and ongoing FDA communication until your product is fully cleared.

Import Alerts are issued for violations including contamination, labeling non-compliance, lack of required FDA registration, use of unapproved additives, or failure to meet safety standards. FDA Registration Assistance identifies the root cause and develops a targeted compliance plan for your specific situation.

The petition typically requires corrective action documentation, evidence of compliance, updated manufacturing and quality control records, and supporting records as requested by the FDA. FDA Registration Assistance prepares and organizes all required documentation for submission.

For most Import Alerts, five consecutive compliant shipments that are examined and released by the FDA are required before a removal petition is accepted. FDA Registration Assistance advises on the specific requirements for your alert type and coordinates the shipment compliance strategy.

In some cases, individual shipments can be released if the importer provides sufficient evidence of compliance at the time of entry. However, DWPE means detention is automatic. FDA Registration Assistance can advise on strategies to facilitate individual shipment releases during the removal process.

It depends on the alert type. Some alerts apply to specific products, while others cover the entire manufacturer or facility. FDA Registration Assistance reviews the scope of your specific alert and advises on which shipments and product lines are impacted.

Fees are based on case complexity, violation type, and the level of documentation required. FDA Registration Assistance provides a customized quote after an initial case review — contact us today for a free consultation.

We respond to all inquiries within 24–48 hours. For urgent Import Alert situations, FDA Registration Assistance prioritizes rapid case assessment to help you begin the resolution process as quickly as possible.

No service provider can guarantee FDA outcomes. However, FDA Registration Assistance maximizes your chances of a successful removal by ensuring your petition is complete, accurate, and supported by strong compliance evidence — minimizing back-and-forth with the FDA.

We serve food manufacturers, dietary supplement producers, cosmetic companies, importers, exporters, brokers, and logistics providers across all FDA-regulated industries. FDA Registration Assistance has experience with Import Alert cases across 135+ countries worldwide.

Visit FDA Registration Assistance to learn more about our Import Alert removal services, or use the contact form below to speak directly with one of our FDA compliance experts. We're ready to help you restore U.S. market access.

Pricing is a Custom Fee scoped to your case — there is no flat rate because Import Alert complexity varies dramatically by charge type, evidence volume, and number of products on the alert. A typical engagement includes case review, identification of the specific Import Alert number and FD&C Act charge cited, root-cause analysis, corrective action plan, evidence package preparation, the formal removal petition per FDA RPM Chapter 9-8, and DIO correspondence through resolution. Most clients bundle the service with FDA Consulting & Shipment Monitoring, U.S. Agent Services, and Label & Ingredient Review — combined engagements typically reduce the per-service rate by 10–20% versus separate purchase. The FDA itself charges $0 to file or process the petition.

Legally yes — but it is strongly discouraged. FDA accepts removal petitions from the manufacturer, importer, U.S. Agent, attorney, or any authorized representative. In practice, petitions filed by a non-specialist (a friend, customs broker, or freight forwarder) are returned with deficiencies the majority of the time, because the petition must follow the exact format in FDA's RPM 9-8 and include specific evidence categories: corrective actions, root-cause analysis, and at least five consecutive compliant entries documented through PREDICT and ITACS. A general broker has no DIO engagement history and no template for these submissions.

If the firm does not respond to FDA requests during a removal review, the petition is administratively closed and DWPE remains in force indefinitely. FDA is not bound by a statutory deadline on removal petitions — RPM 9-8 lists no required turnaround. Practical consequences of non-response by your side include continued shipment refusal under FD&C Act § 801(a), accumulating storage and demurrage at the port, forced re-export or destruction within 90 days under 21 CFR 1.94, and in some cases referral for warning letter or expanded Import Alert scope. FDA Registration Assistance manages every DIO follow-up so the petition stays active.

You cannot simply rename a firm to escape an Import Alert — FDA's OASIS and FACTS databases flag the underlying FEI (FDA Establishment Identifier) and physical address, so the listing follows the facility regardless of corporate restructuring. Legitimate updates (corrected legal name, new U.S. Agent, address correction) are submitted via FURLS for the registration and through a separate written request to the FDA Division of Import Operations referencing the Import Alert number. The Import Alert listing itself is updated only through FDA action, never by the firm. FDA Registration Assistance coordinates both filings in parallel.

It applies to every FDA-regulated category. Food and dietary supplements fall under Import Alerts cited to FD&C Act § 402/403. Cosmetics now fall under MoCRA-era enforcement (21 U.S.C. § 364) and may be cited for unsafe ingredients or unregistered facilities. OTC and Rx drugs are subject to Import Alerts cited to § 505 (unapproved new drugs) and the Drug Quality and Security Act. Medical devices are cited under § 510(k) deficiencies and 21 CFR Part 807 registration violations. The removal procedure under RPM 9-8 is the same across all categories.

Once your firm or product is on a public Import Alert, every U.S. inbound shipment is detained under DWPE — meaning Amazon FBA inbound appointments are missed, Walmart Marketplace inventory cannot replenish, and Shopify direct-to-consumer fulfillment stalls. Amazon and Walmart compliance teams routinely query the public FDA Import Alert database and suppress ASINs or delist SKUs for cited firms. Removal restores import flow, but reactivating suppressed listings on the platforms often takes an additional 30–90 days after FDA delisting.

The FDA Import Alert database (accessible from FDA.gov under Import Program) lists every active alert with its number, charge, criteria, and Red List/Green List of firms. Search by Import Alert number, product, country, or firm name. The database is updated continuously, so a firm can be added or removed without notification. FDA Registration Assistance conducts a full Import Alert audit across all alerts for any firm we engage with, including alerts the firm may not know about.

A country-wide Import Alert applies to all products of a given type from a specific country (for example, IA 16-81 historically covered seafood from certain countries for nitrofuran residues). A firm-specific Import Alert names individual firms by FEI and address. Country-wide alerts allow compliant firms to apply for the Green List exemption with enhanced testing per shipment, while firm-specific alerts require the standard five-entry petition. Removal evidence and petition format differ between the two — country-wide listings demand analytical data per entry, firm-specific listings demand systemic CAPA evidence.

Sometimes yes — reconditioning is permitted under 21 CFR 1.95 for specific violation types such as labeling errors, missing nutrition facts, or contamination removable by physical separation. The importer files Form FDA 766 (Application for Authorization to Recondition) before action begins. Reconditioning is not allowed for unapproved drugs, certain pesticide residues, or banned additives. Successful reconditioning admits the individual shipment but does not lift DWPE — the firm still needs the five-entry petition for delisting.

FDA does not publish a guaranteed timeline. Industry experience shows simple petitions (labeling-only alerts, single product, complete five entries) are commonly decided in 3–6 months from a complete submission, while complex petitions (contamination alerts, multi-product, country-wide alerts) often run 9–18 months. The single biggest accelerator is a first-submission RPM 9-8-compliant package — deficient petitions can add 6–12 months of back-and-forth. Until removal is granted, DWPE remains in force.

Yes — a single facility can appear on several alerts simultaneously (for example, one for Salmonella, one for unapproved colorants, one for FSVP failure). Each Import Alert is administered separately by FDA Division of Import Operations and requires its own dedicated petition with evidence tailored to that specific charge. A single petition cannot cover multiple alerts. We routinely manage parallel petitions for clients listed on three or more alerts at the same time.

No — FDA does not provide advance notice. Listing typically follows a documented violation (detained shipment, inspection finding, Warning Letter, FSVP failure), and the firm usually learns of the listing only when the next shipment is detained under DWPE or by checking the public Import Alert database. There is no formal "appeal" — the firm can request reconsideration under 21 CFR 1.94, but the practical path back to compliance is the standard RPM 9-8 removal petition with corrective evidence.

Yes for foreign firms. Under 21 CFR 1.227, every foreign FDA-registered facility must maintain a U.S. Agent with a physical U.S. street address (P.O. Box is not acceptable), reachable 24/7. The U.S. Agent is the legal point of contact for FDA correspondence on the removal petition. Without an active U.S. Agent, DIO will not accept follow-up communications, and the petition stalls. U.S. Agent Services are commonly bundled with removal engagements for this reason.

Removed firms are monitored closely by FDA PREDICT and can be re-listed on a single repeat violation, often without a new Warning Letter. Prevention requires ongoing shipment monitoring, continued root-cause controls (the original CAPA cannot be relaxed), supplier verification under FSVP if applicable, annual label audits, and active U.S. Agent coverage. Most clients pair Import Alert removal with FDA Consulting & Shipment Monitoring specifically to flag any pre-detention PREDICT signal before it becomes a re-listing event.